About
Novo Nordisk appears at No. 137 in the 2026 Global 2000, a multi-factor ranking based on sales, profits, assets and market value. The company is headquartered in Bagsværd, Denmark and operates primarily in drugs & biotechnology. Reported figures used for the ranking include $50.9B in sales, $18.9B in profit, $86.2B in assets and a market value of $206.9B.